Watch BBIO. Know when insiders buy.
One email the day a filing lands. Free.
Work order
38
FLAG · insiders 25, shorts 50
Insiders, 90 days
−$3.7M
net selling · 0 buys, 7 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
2 / 15
tracked funds hold it
Calls on record
0
nobody we score has called it yet
MKT CAP $14.6BP/E —DIV YIELD —FCF YIELD -2.98%REV TTM $713.1M +202.4%NET INCOME −$702MNET DEBT $2B52W 49.00 – 90.17NEXT EARNINGS Oct 28 EST.SEC XBRL · TTM TO Invalid Date
Dividends
BridgeBio Pharma, Inc. reports no common dividend in its last four quarters.